Zhengye Biotechnology Holding ZYBT
NASDAQ ZYBT
$1.52 -0.02 (-1.30%)
As of: Nov 11, 2026 · 3:58 PM EST

Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025)

Updated

Zhengye Biotechnology Holding's Receivables - Other came in at $104,053 for the quarter ended Dec 31, 2025, up 1.3% from $102,741 a year earlier.

Analysis

Zhengye Biotechnology Holding (ZYBT) Receivables - Other (2023 - 2025) Analysis & Trends

As of Dec 31, 2025, Zhengye Biotechnology Holding's Receivables - Other was -$23.39 million.

  • Going back by year, Receivables - Other was $360,000 in the year ended Dec 31, 2024 (+95.4%) and $184,236 in the year ended Dec 31, 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Zhengye Biotechnology Holding 72.98 Mn 69.39 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 105,487.34
Jun 30, 2025 103,000.00
Dec 31, 2024 101,122.21
Dec 31, 2023 183,199.66
API Access

Zhengye Biotechnology Holding Receivables - Other API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=receivables-other&ticker=ZYBT&period=max&api_key=YOUR_API_KEY